🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jianhui Ma

Acadia Pharmaceuticals (United States)

ORCID: 0000-0002-9374-2673

Also affiliated with Zen-Noh (Japan), Arena Pharmaceuticals (United States), Tracon Pharmaceuticals (United States)

ChemistryMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.588Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

Neuro-Oncology(2022)10.1093/neuonc/noac067
Top 33%
0.588DataRank
Top 33%8 citations

Brett Taylor, Matthew Lee, Nanyun Tang, Sen Peng, Rita Bybee +11 more

Papers

Driven by 5 papers — median percentile 67. Top paper: “Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors”.

Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

Neuro-Oncology(2022)10.1093/neuonc/noac067
Top 33%
0.588DataRank
Top 33%8 citations

Brett Taylor, Matthew Lee, Nanyun Tang, Sen Peng, Rita Bybee +11 more

Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells

Nature Communications(2020)10.1038/s41467-020-14312-1
N/A
0DataRank · unranked
60 citations

Isaac A. Chaim, Jorge A. Benítez, Sebastian Markmiller, Alison D. Parisian, Robert F. Hevner +16 more

Dynamic multi-OMICs of glioblastoma reveal sensitivity to neddylation inhibition dependent on nuclear PTEN and DNA replication pathways: Nuclear PTEN mediates MLN4924 sensitivity in GBM

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.21.212571
N/A
0DataRank · unranked
0 citations

B Taylor, M Lee, N Tang, S Peng, R Bybee +11 more

Gα12 signaling regulates transcriptional and phenotypic responses that promote glioblastoma tumor invasion

Scientific Reports(2023)10.1038/s41598-023-49164-4
N/A
0DataRank · unranked
8 citations

Shunichiro Miki, Briana C. Prager, Jianhui Ma, Anthony Y. Jeong, Jacqueline Lara +8 more

Glioblastoma vulnerability to neddylation inhibition is dependent on PTEN status, and dysregulation of the cell cycle and DNA replication

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae104
N/A
0DataRank · unranked
1 citations

Nanyun Tang, Yue Hao, Matthew Lee, Sen Peng, Rita Bybee +10 more